Assessing Antigen-Specific T-Cell Functionality with Dendritic Cell/CD8+ T Cell Co-culture

Sponsored by:

STEMCELL Technologies Inc.
Date:

Webinar Summary

  • Learn how to use DC/CD8+ T cell co-culture to study the antigen-specific responses of CD8+ T cells, including their activation, proliferation, cytokine production, and cytotoxic killing activity.
  • Explore the features of STEMCELL's ImmunoCult Medium and Activators.
  • Isolate antigen-specific cells with EasySep Release.

Webinar Topics

STEMCELL Technologies Inc.

Who Should Attend?

Scientist.com

Presenters

Catherine Ewen

STEMCELL Technologies (Research & Development)
Senior Scientist

Dr. Catherine Ewen works as a Senior Scientist at STEMCELL Technologies, where she brings proof-of-concept products to market. She is passionate about scientific discovery and technological advancements, and her top goal has always been to build effective and collaborative teams that are driven by innovation and pursue scientific excellence.

Read More

Sponsor

STEMCELL Technologies Inc.

STEMCELL Technologies develops specialty cell culture media, cell isolation products and accessory reagents for life science research. Generate hPSC-derived cerebral organoids for a physiologically relevant in vitro model system with the STEMdiff Cerebral Organoid Kit. Use BrainPhys Neuronal Medium to culture active hPSC- and primary tissue-derived neurons in a physiological environment. The NeuroCult product line for primary and CNS-derived neural stem cells includes 30+ media and supplements, culture assays and differentiation kits. For human neurological disease modeling, the STEMdiff Neural System supports every step in your iPS-neural workflow, from neural induction to downstream differentiation.

Content Partners

Scientist.com

Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.

We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.

Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.

Related Content

Related Content